AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06617286 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD30 CAR T-cell
Description: After MAC and AutoHSCT patients will receive CD30+ CAR T-cells (Phase 1B dose level 1 - 1x108/m2 (max 2.5x108) or dose level 2 - 2x108/m2 (max 5.0 x108) 21-42 days after the AutoHSCT and the RP2D dose level obtained in the Phase IB part administered in the Phase II portion.
Study NCT06712914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagPro X100 by MagVenture
Description: Participants will receive 5 session per day of TBS for 6 days (30 sessions total). Six treatment days have to occur within a 2 week period. Each session will be comprised of 1800 pulses, using a MagVenture MagPro X100.
Study NCT06717490 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulphate
Description: In patients allocated to the MS group, a fixed dose of magnesium sulfate diluted in a fixed volume of natural saline will be administered intravenously.~Thromboelastometry will be performed pre and post magnesium administration.
Study NCT06717490 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Drug
Description: In patients allocated to the NS group, a fixed dose of natural saline will be administered intravenously, through a fixed volume of solution.~Thromboelastometry will be performed pre and post magnesium administration.
Study NCT06716944 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: self-acupuncture
Study NCT06718114 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immediate urinary catheter removal
Description: Immediate urinary catheter removal indicates that the urinary catheter will be removed immediately after surgery.
Study NCT06718114 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: early removal of urinary catheter
Description: The urinary catheter will be kept after surgery and be removed within 48 hours after surgery.
Study NCT06714968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital
Description: After the pre-test application is completed, the students in the experimental group will be allowed to install the designed game application on their phones. After the installation process, students will be allowed to play the game for 2 weeks. After 2 weeks from the date of downloading the game, access to the game will be automatically blocked. After completing the application steps, when the student thinks that he/she is ready to apply the post-test, he/she will be able to perform the post-test application. In the post-test application, there will be no repeated return of the student to the questions or multiple answer submission. Two weeks after the application is completed, the knowledge test will be applied to the students again in order to objectively evaluate the learning. In this process, students will be prevented from accessing the application.
Study NCT06716918 — intervention group
Intervention type: DRUG
Intervention: Corticosteroid Injection
Description: Participants who have received antenatal corticosteroids (betamethasone or dexamethasone) prior to cesarean section as part of their prenatal care.
Study NCT06715280 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Riociguat (Adempas)
Description: Oral riociguat administered according to established dose-adjustment scheme. Riociguat will be administered starting at at 1mg three times per day. If patient systolic blood pressure maintains at 95mmHg or higher, the dose will be increased 0.5mg every 2 weeks up to a maximum dose 2.5mg three times per day over 8-week period
Study NCT06716411 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Sterile insertive needles are applied by licensed, experienced practitioners.
Study NCT06716411 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: Sterile insertive needles are applied by licensed, experienced practitioners.
Study NCT06713278 — intervention group
Intervention type: OTHER
Intervention: masseter muscle thickness measurement
Description: masseter muscle thickness measurement with ultrasonography
Study NCT06713278 — intervention group
Intervention type: OTHER
Intervention: scales
Description: headache impact scale (HIT-6) Short SF-36 fibromyalgia total score widespread pain index symptom severity scale fibromyalgia impact questionnaire (FIQ)
Study NCT06716489 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Participants will undergo an aerobic exercise training program on a motorized treadmill at an intensity corresponding to 60-70% of their heart rate reserve (calculated by adding baseline heart rate to 60-70% of reserve heart rate). The program will last 16 weeks and will consist of three 1-hour, 10-minute sessions per week, divided into four phases: a 5-minute warm-up at an intensity below the target exercise heart rate (baseline + 30-40% of the reserve heart rate); a 50-minute main exercise session at the target exercise heart rate intensity; a 5-minute cool-down at an intensity below the target exercise heart rate; and a 10-minute relaxation and general stretching phase. This structured exercise protocol was designed to evaluate the effects of aerobic exercise on sensory perception, musculoskeletal alterations, and psychosocial factors in patients with migraine.
Study NCT06472037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: 10mg/kg，IV，D1，Q3W
Study NCT06472037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1000mg/m2，IV，D1、D8、D15，Q4W
Study NCT06472037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-Paclitaxel
Description: 125mg/m2，IV，D1、D8、D15，Q4W
Study NCT06447766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feeding Families Your Way Program
Description: Feeding Families Your Way is a video-based education program delivered by the University of Rhode Island Supplemental Nutrition Assistance Program - Education (SNAP-Ed).
Study NCT06389058 — intervention group
Intervention type: OTHER
Intervention: Recommendation for the diagnoses and treatment of Severe Asthma
Description: No intervention planned in this phase for the patients. Recommendations to be developed for healthcare and condition.
Study NCT04959422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active scheduling
Description: Active scheduling, tracking and rescheduling, if necessary.
Study NCT05419869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALTO-100 PO Tablet
Description: Two tablets daily
Study NCT06544044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Mindfulness' Self compassion
Description: session includes mindfulness exercises like breath awareness and body scans, self-compassion practices like self-kindness meditations, and emotional regulation strategies such as cognitive reappraisal and response modulation. Discussions focus on applying mindfulness and self-compassion to manage difficult emotions, improve interpersonal interactions, and reduce aggression. Home practice assignments encourage students to integrate mindfulness and self-compassion into their daily lives. The program curriculum is based on existing evidence-based interventions, including mindfulness-based stress reduction for teens.
Study NCT05804929 — intervention group
Intervention type: OTHER
Intervention: Observation without intervention
Description: Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.
Study NCT05125003 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FITBI
Description: parents learn to identify high probability cues in the environment that can elicit RRBI symptoms and teach their child to inhibit repetitive behaviors and instead replace them with alternative and flexible play behaviors; and (b) teach parents how to embed this FITBI approach into their child's everyday routines
Study NCT05125003 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parental Education
Description: Sessions will cover relevant information on young children with ASD, including understanding the ASD diagnosis, developmental changes in ASD, educational planning, advocacy, and treatment options.
Study NCT05626933 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Buccinator myomucosal flap with Furlow palatoplasty
Description: Anatomical restoration concept using Buccinator myomucosal flap with Furlow palatoplasty is an effective technique for lengthening the palate and improving speech outcomes
Study NCT06218810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab + bevacizumab + FOLFOX
Description: Cadonilimab + bevacizumab + FOLFOX
Study NCT06487299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferrous Lactate
Description: The injection solution was 3 ferrous lactate (10ml:0.1g iron) mixed with 20ml saline.
Study NCT06487299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iron sucrose
Description: The injection was 3 shots of ferrous lactate (5ml:100mg iron) mixed with 35ml saline.
Study NCT06487299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% NaCl solution
Description: The same volume and color as Iron sucrose.
Study NCT04630925 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: isCGM
Description: As previously described
Study NCT05771714 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CareSuperb COVID-19 Antigen Home Test Kit
Description: At home COVID-19 antigen test kit
Study NCT06259318 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kanasina Gulabi
Description: Kanasina Gulabi is a theory-driven, educational-behavioral intervention designed to improve the quality of life and diabetes management among young adults living with type 2 diabetes in Mysore district, South India. In this intervention, young adults with type 2 diabetes were matched to non-specialist peer navigators -- trained young adult peers who were also managing type 2 diabetes -- and developed action plans to improve their physical and mental health outcomes. Intervention components included group education, mindfulness activities, self care activity tracking, and phone follow-ups to address knowledge gaps and misinformation about type 2 diabetes, build self-efficacy for type 2 diabetes-related self care activities, and provide emotional support for diabetes management.
Study NCT06393842 — intervention group
Intervention type: DEVICE
Intervention: Cardiopulmonary Management Wearable Device
Description: Fluid status and congestion can be determined by the CPM wearable device and correlates with non-invasive measures and biochemical markers of congestion and changes in congestion.
Study NCT05850767 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Description: Participants will stay fully awake for 24 hours
Study NCT05456529 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib Cream
Description: Ruxolitinib cream 1.5% twice daily (BID) during the continuous and LTS treatment period.
Study NCT04176666 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NettOpp
Description: NettOpp is a mobile application for adolescents aged 11-16 years who have been exposed to cyberbullying or cyberaggression.
Study NCT05660603 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: patients will receive standard general anesthesia
Study NCT05660603 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LSP
Description: patients will receive standard general anesthesia followed by ultrasound-guided combined lumbar and sacral plexus blocks with 40 ml of bupivacaine 0.25%.
Study NCT05660603 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CP
Description: patients will receive standard general anesthesia followed by ultrasound-guided circum-psoas blocks with 40 ml of bupivacaine 0.25%.
Study NCT05660603 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: ultrasound
Study NCT06323070 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-fat cookies
Description: To determine the effects of low-fat cookie consumption on physiological indicators of wellness regarding sexual, skin, and gut health
Study NCT05566743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: maintenance capecitabine after 4 months of FOLFRINOX
Study NCT05566743 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: follow up
Description: follow up after 4 months of FOLFRINOX
Study NCT06323070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Watermelon
Description: To determine the effects of watermelon consumption on physiological indicators of wellness regarding sexual, skin, and gut health
Study NCT04982991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RIPK1 inhibitor
Description: Capsule Oral
Study NCT05357833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferumoxytol infusion
Description: Subjects will receive a single, weighted dose of intravenous ferumoxytol (4 mg/kg) diluted in 50 mL of saline.
Study NCT05357833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoteridol
Description: Subjects will receive a single, weighted dose of intravenous gadoteridol (0.2 mL/kg).
Study NCT05357833 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI Brain and Cervical Spine
Description: 3T MR imaging of the brain and cervical spine pre- and post-administration of gadolinium, then pre- and 96 hours (±24 hours) post-administration of ferumoxytol
Study NCT05385211 — intervention group
Intervention type: OTHER
Intervention: Frequency of hypoglycemia in people with type 1 diabetes and exocrine pancreatic insufficiency
Description: Blood samplings; Glucose monitoring; CFTR variants
Study NCT05027919 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Morphine
Description: 30mg subcutaneous injections of morphine 4 times daily on days 1 through 5.
Study NCT05027919 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Naloxone + lofexidine pretreatment
Description: 0.4mg naloxone injection during the Naloxone challenge + pretreatment with oral lofexidine (25% of max daily dose scheduled during lofexidine taper)
Study NCT05027919 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Naloxone + placebo pretreatment
Description: 0.4mg naloxone injection during the Naloxone challenge
Study NCT05027919 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Lofexidine
Description: Oral Lofexidine dosed per FDA label (4 times daily) on days 6 through 10.
Study NCT05913479 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mucogyne Gel
Description: At inclusion visit (V0), the Investigator will ask the subject to apply MUCOGYNE® Gel as described in the Instructions For Use, i.e., internally, one application 2 to 3 times a week until symptoms improve during 5 weeks (D35 +/- 3)
Study NCT05450835 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: OGT group
Description: In OGT group,the nasogastric tube was pulled out 3 cm from the oesophagal lumen to connect with the OGT. Meanwhile, the OGT was sleeved on anvil fork extracorporeally and the linear stapler was put into abdomen through trocar on the right side and then cartridge fork was inserted through jejunum opening towards the oral side of the lumen. Next, the anvil fork sleeved with OGT insert into the oesophageal mucosa canal by movement of the connection of fork -OGT -gastric tube.
Study NCT05450835 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Overlap group
Description: In overlap group, the oesophagojejunostomy was performed as reported by Inaba et al.
Study NCT06528899 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical Therapy
Description: Assessment and/or treatment by physitoherapist during the visit
Study NCT05579730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
Description: Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
Study NCT05579730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketotifen fumarate ophthalmic solution 0.035%
Description: Ketotifen fumarate ophthalmic solution 0.035%
Study NCT05066763 — intervention group
Intervention type: OTHER
Intervention: Non-interventional
Description: non-interventional
Study NCT05579730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate ophthalmic solution 0.025%
Description: Brimonidine tartrate ophthalmic solution 0.025%
Study NCT05579730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vehicle ophthalmic solution
Description: Vehicle ophthalmic solution
Study NCT05404971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Joint integrity exercises
Description: patients with three strokes followed by 3 sec rest period. Kinaesthetic stimulations will be given to the patients to increase proprioception proprioception in neglected limb in sitting position, the limb on the affected side of the body is supported and moved by the examiner in various directions but movement is only at one joint at a time. Stereognosis by placing the object in the patient's hand for a maximum 30 seconds with close eyes. Identification is by naming, description or by pair matching with an identical set.
Study NCT05404971 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mirror therapy
Description: A 5 cm × 35 cm mirror will be placed vertically between the upper limbs on the table, with the reflecting surface facing the uninjured limb. Patients will be asked to observe the motion of the upper limb on the uninjured side and imagine that the limb on the affected side was in motion, imagine the motion of the affected limb the same as that observed on the uninjured side, and complete 6 movements including shoulder joint forward flexion, elbow joint flexion and extension, forearm forward and backward rotation, wrist joint flexion and extension, finger extension and grasping, and thumb abduction. The participants will be asked to perform each movement for 5 min and try to reach the maximum range of motion of the joints. Training will be completed for 30 min per day) Session will be 3 days per week. Per day session will be for 30 minutes.
Study NCT06320600 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: It's an observational study, no intervention included
Study NCT06375083 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: The computerized Cognitive Behavioral Therapy for Suicide Prevention (cCBT-SP) course is comprised of 12 online sessions and is augmented by use of a companion workbook. The computerized Cognitive Behavioral Therapy for Depression (cCBT-D) course is comprised of 12 online sessions.
Study NCT05335733 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Intraoral examination, saliva, dental plaque and serum collection.
Description: Probing pocket depth will be defined as the distance in millimeters from the gingival margin to the base of the gingival sulcus measured using a manual probe (Michigan 0 probe with Williams Markings) in all the teeth present except for third molars. Similarly, clinical attachment level (CAL) will be measured as distance from cementoenamel junction to the base of pocket and will be recorded manually to the nearest millimeter marking on probe.~1 mililiter of saliva will be obtained by each participant. Subgingival dental plaque will be collected with sterile endodontic paperpoints from mesial sides of each natural teeth without a prostethic restoration. Serum samples will be also collected at the time of visit.
Study NCT05589844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: Undergo standard of care allogeneic hematopoietic stem cell transplant
Study NCT05589844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Correlative studies
Study NCT05589844 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CMV pp65 Peptide-loaded Alpha-type-1 Polarized Dendritic Cell Vaccine
Description: Given intradermally
Study NCT06114394 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: UPV/EHU technique (Aguirre-Zorzano et al 2017)
Description: The UPV/EHU technique (Aguirre-Zorzano et al., 2017) begins with the elevation of the full thickness flap (FTF) in the palate and an intrasulcular incision performed with a number 12 blade, preserving the papillae in the interproximal spaces. Then, the FTF is dissected with a 15c blade, holding the flap with tissue forceps, leaving the epithelium and a thin layer of the connective tissue in the flap, so that the underlying connective tissue can be harvested. After that the flap is sutured.
Study NCT06114394 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single incision technique (Huerzeler & Weng 1999)
Description: The CTG is harvested with the single incsion technique described by Huerzeler \& Weng in 1999.
Study NCT04791033 — intervention group
Intervention type: PROCEDURE
Intervention: Hysterectomy
Description: Elective procedure with hysterectomy due to benign gynecological condition
Study NCT05833971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cadonilimab+chemotherapy
Description: cadonilimab plus cisplatin and Nab-PTX, Q3W
Study NCT04297826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harvest for Health
Description: Please see previous description
Study NCT04856956 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diagnostic decision support software
Description: Comparing use of decision support group (intervention group) to use only of common literature (control group) among pediatric trainees diagnosing patients with possible rheumatologic disorder
Study NCT05249985 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NMES
Description: Participants will undergo 12 weeks of neuromuscular electrical stimulation- (NMES) based resistance training on the quadriceps.
Study NCT05249985 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NMES
Description: Participants will undergo 12 weeks of neuromuscular electrical stimulation- (NMES) based resistance training on the quadriceps.